Two years later, the anti-endoglin chimeric antibody TRC105 was conjugated to the NIRF dye IRDye 800CW, and subsequently injected intravenously in 4T1 breast cancer-bearing mice [97]. This evidence concerns the gene ENG and breast carcinoma.